The Problem
One of the primary challenges in diagnosing bipolar disorder is that its symptoms can often be mistaken for other mental health conditions, such as depression, anxiety disorders, or even schizophrenia.
This is because many of the symptoms of bipolar disorder, such as mood swings, changes in energy levels, and difficulty sleeping, can also be present in these other conditions.
This can make it difficult for clinicians to accurately identify bipolar disorder based on symptoms alone.
Another factor that makes bipolar disorder difficult to diagnose is that many people with the condition may not recognize that they have it, or may not seek treatment until their symptoms become severe.
This can be due to a lack of awareness about bipolar disorder or the stigma associated with mental illness, which can prevent people from seeking help. In addition, bipolar disorder can sometimes take years to fully develop, with symptoms appearing gradually over time.
This can make it difficult for clinicians to identify the condition in its early stages and may result in misdiagnosis or delayed diagnosis.
The Solution
One approach that physicians can use to help diagnose bipolar disorder and distinguish it from other mental health conditions is through the use of blood biomarkers.
Biomarkers are substances that can be measured in the blood that are associated with a particular disease or condition. Using a combination of cutting-edge analytical methods and artificial intelligence, Psykonos has identified a combination of proprietary blood biomarkers that can provide physicians with valuable information to help diagnose bipolar disorder and distinguish it from major depressive disorder.